EUVIMEDEUVIMED entdecken
EditorialLeitlinieOpen Access

CSCO breast cancer management guidelines 2022: Australian perspective

Chen Han Yong, Anurag Gupta, Rohit Joshi

Translational Breast Cancer Research · 2022-10 · 3 · 36-36

DOI: 10.21037/tbcr-22-46 ↗

Kurz gefasst

Editorial in der Zeitschrift Translational Breast Cancer Research, 2022-10. Verfasst von Chen Han Yong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Lyell McEwin Hospital, Adelaide, South Australia, Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medical Oncology, Lyell McEwin Hospital, Adelaide, South Australia, Australia.
  • Department of Breast & Endocrine Surgery, Lyell McEwin and Modbury Hospitals, Adelaide, South Australia, Australia.
  • The University of Adelaide, Adelaide, South Australia, Australia.

Zitieren

APA

Yong, C. H., Gupta, A., & Joshi, R. (2022). CSCO breast cancer management guidelines 2022: Australian perspective. Translational Breast Cancer Research, 3, 36-36. https://doi.org/10.21037/tbcr-22-46

Vancouver

Yong CH, Gupta A, Joshi R. CSCO breast cancer management guidelines 2022: Australian perspective. Translational Breast Cancer Research. 2022;3:36-36. doi:10.21037/tbcr-22-46

BibTeX
@article{Yong2022,
  author = {Yong, Chen Han and Gupta, Anurag and Joshi, Rohit},
  title = {CSCO breast cancer management guidelines 2022: Australian perspective},
  journal = {Translational Breast Cancer Research},
  year = {2022},
  volume = {3},
  pages = {36--36},
  doi = {10.21037/tbcr-22-46}
}
Kostenlos starten →